Abbott Laboratories (ABT)
Receivables turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 41,950,000 | 40,109,000 | 43,653,000 | 43,075,000 | 34,608,000 |
| Receivables | US$ in thousands | 6,925,000 | 6,565,000 | 6,218,000 | 6,487,000 | 6,414,000 |
| Receivables turnover | 6.06 | 6.11 | 7.02 | 6.64 | 5.40 |
December 31, 2024 calculation
Receivables turnover = Revenue ÷ Receivables
= $41,950,000K ÷ $6,925,000K
= 6.06
The data provided shows that Abbott Laboratories' receivables turnover is not available for the years ending December 31, 2020, 2021, 2022, 2023, and 2024. The receivables turnover ratio indicates how efficiently a company is collecting payments from its customers. However, the absence of data for this ratio makes it challenging to evaluate the effectiveness of Abbott Laboratories' accounts receivable management during these years. It is important for Abbott Laboratories to track and disclose this ratio in order to provide stakeholders with insights into the company's liquidity and credit management.
Peer comparison
Dec 31, 2024